IMPACT OF PATIENT FRAILTY ON ONE-YEAR MORTALITY ACROSS CHA2DS2-VASC SCORES: FROM THE TREAT-AF STUDY

2019 
The CHA2DS2-VASc score, validated in older and morbid cohorts, guides treatment decisions in patients with atrial fibrillation (AF). We previously found a claims-based frailty phenotype was associated with the CHA2DS2-VASc score and theorize that frailty may be an important driver of outcomes across
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []